About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Maryland | 149 Studies

Clinical Trials Brain CancerMaryland

Brain Cancer Clinical Trials in Maryland

Find 149 clinical trials for brain cancer near Maryland. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 101-120 of 149 trials

TerminatedTesting the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain CancerThis phase I trial studies the side effects and best dose of navtemadlin in treating patients with glioblastoma (brain cancer) that is newly diagnosed or has come back (recurrent).NCT03107780·Birmingham, Alabama and 10 others CompletedStudy of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsThe purpose of this study was to investigate the activity of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive low…NCT02684058·Orange, California and 56 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedSunitinib to Treat Recurrent Brain CancerBackground: One way tumors are able to grow is by forming new blood vessels that supply them with nutrients and oxygen.NCT00923117·Bethesda, Maryland

TerminatedPost-approval Study of NovoTTF-100A in Recurrent GBM PatientsThis is a non-randomized, concurrent control study, designed to confirm that the efficacy of the NovoTTF-100A System in patients with recurrent GBM treated in a real life settings…NCT01756729·Birmingham, Alabama and 11 others

TerminatedOptune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)This protocol is designed to generate and provide preliminary data to determine the safety and activity of combination therapy using tumor treating fields (TTFields…NCT01925573·Baltimore, Maryland

CompletedBlood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain TumorsThe purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects…NCT05383872·Los Angeles, California and 16 others

CompletedRebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaPhase II trial to study the effectiveness of rebeccamycin analogue in treating children who have solid tumors or non-Hodgkin's lymphoma.NCT00006102·Birmingham, Alabama and 225 others

CompletedMotexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the BrainRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as motexafin gadolinium may make the tumor cells more sensitive to radiation therapy.NCT00032097·Baltimore, Maryland

UnknownA Study of 131I-TM601 in Adults With Recurrent Malignant GliomaThe purpose of this study is to evaluate the safety and effectiveness of 131I-TM601 in the treatment of adult patients with progressive or recurrent malignant gliomas.NCT00683761·Chicago, Illinois and 3 others

Active not recruitingPediatric Long-Term Follow-up and Rollover StudyA roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.NCT03975829·Phoenix, Arizona and 53 others

CompletedEvaluation of Factors in Human Brain TumorsPresently, patients with primary malignant brain tumors have a life expectancy of 15 weeks following surgery unless they receive additional types of therapy (chemotherapy…NCT00001171·Bethesda, Maryland

CompletedSorafenib in Treating Patients With Recurrent or Progressive Malignant GliomaThis phase I trial is studying the side effects and best dose of sorafenib in treating patients with recurrent or progressive malignant glioma.NCT00093613·Birmingham, Alabama and 9 others

TerminatedPharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapyRATIONALE: Studying samples of blood in the laboratory from patients receiving temozolomide may help doctors learn how temozolomide works in the body.NCT00471653·Duarte, California and 1 other

Active not recruitingSonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMThe brain is protected from any toxic or inflammatory molecule by the blood-brain barrier (BBB). This physical barrier is located at the level of the blood vessel walls.NCT05902169·Phoenix, Arizona and 55 others

RecruitingPrecision Radiotherapy Enabled by Molecular MRIThis is a research study to determine if a novel molecular magnetic resonance imaging (MRI) technique, called amide proton transfer (APT) imaging, is useful in identifying the…NCT07512154·Baltimore, Maryland

TerminatedBortezomib in Treating Patients With Recurrent GliomaPhase I trial to study the effectiveness of bortezomib in treating patients who have recurrent glioma.NCT00006773·Baltimore, Maryland

CompletedA Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaThe purpose of this research study is to find out whether adding an experimental vaccine called rindopepimut (also known as CDX-110) to the commonly used drug bevacizumab can…NCT01498328·Birmingham, Alabama and 44 others

TerminatedAXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing SurgeryThis phase I trial studies how well AXL inhibitor BGB324 works in treating participants with glioblastoma that has come back who are undergoing surgery.NCT03965494·Birmingham, Alabama and 5 others

CompletedSuramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Suramin may stop the growth of glioblastoma multiforme by stopping blood flow to the tumor. Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00004073·Birmingham, Alabama and 8 others

CompletedTalabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsRATIONALE: Talabostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00303940·Bethesda, Maryland

PreviousPage 6 of 8Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia